Compatibility Assessment of Novel Orodispersible Film Vehicle for Personalized Medicine with Selected Active Pharmaceutical Ingredients

被引:0
|
作者
Polonini, Hudson C. [1 ]
Ferreira, Anderson O. [1 ]
Raposo, Nadia R. B. [2 ]
da Silva, Paulo Jose L. C. [2 ]
Brandao, Marcos Antonio F. [2 ]
机构
[1] Fagron BV, Fascinatio Blvd 350, NL-3065 WB Rotterdam, Netherlands
[2] Fed Univ Juiz De Fora UFJF, Res & Innovat Ctr Hlth Sci, Juiz De Fora, MG, Brazil
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 11期
关键词
orodispersible films; personalizing medicine; compatibility; stability; compounding pharmacy;
D O I
10.3390/jpm13111565
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Orodispersible films (ODFs) are solid pharmaceutical forms for rapid local or systemic release of active ingredients. They are formed by a water-soluble polymer film that hydrates rapidly, adhering and dissolving immediately when placed on the tongue or in the oral cavity. In this paper, we describe the compatibility and disintegration times of compounded ODFs using OrPhylloTM, a new ready-to-use-vehicle, and APIs from different pharmacological classes, such as 5-hydroxytryptophan (5-HTP) 50 mg, bromopride 5 mg, coenzyme Q10 20 mg, melatonin 3 mg, resveratrol 5 mg, tadalafil 10 mg, vitamin B12 1 mg, or vitamin D3 2000 UI. ODFs were compounded and, subsequently, the samples were assayed using HPLC at initial (t = 0), 7 days (t = 7), 14 days (t = 14), 30 days (t = 30), 60 days (t = 60), 90 days (t = 90), 120 days (t = 120), 150 days (t = 150), and 180 days (t = 180) after compounding. Given the percentage of recovery of the APIs within the films, the beyond-use date of the final products (API + vehicle) was at least 90 days for vitamin D3, 150 days for bromopride and 5-HTP, and 180 days for coenzyme Q10, tadalafil, vitamin B12, resveratrol, and melatonin, when stored at room temperature. The average disintegration time was 46.22 s. This suggests that the OrPhylloTM vehicle is suitable for compounding ODFs with APIs from different pharmacological classes, with good compatibility and fast disintegration.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] A novel application of α-glucosyl hesperidin for nanoparticle formation of active pharmaceutical ingredients by dry grinding
    Tozuka, Yuichi
    Imono, Masaaki
    Uchiyama, Hiromasa
    Takeuchi, Hirofumi
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 79 (03) : 559 - 565
  • [22] Co-Crystals: A Novel Approach to Modify Physicochemical Properties of Active Pharmaceutical Ingredients
    Yadav, A. V.
    Shete, A. S.
    Dabke, A. P.
    Kulkarni, P. V.
    Sakhare, S. S.
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 71 (04) : 359 - 370
  • [23] Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredients
    Zech, Stephan G.
    Carr, Michael
    Mohemmad, Qurish K.
    Narasimhan, Narayana I.
    Murray, Christopher
    Rozamus, Leonard W.
    Dalgarno, David C.
    [J]. JOURNAL OF ANTIBIOTICS, 2011, 64 (09): : 649 - 654
  • [24] Are pharmaceuticals potent environmental pollutants?: Part I:: Environmental risk assessments of selected active pharmaceutical ingredients
    Carlsson, Carina
    Johansson, Anna-Karin
    Alvan, Gunnar
    Bergman, Kerstin
    Kuhler, Thomas
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2006, 364 (1-3) : 67 - 87
  • [25] Carbonization of Invasive Plant Species—Novel Route for Removal of Active Pharmaceutical Ingredients via Adsorption
    Stojanović, Jevrem
    Milojević-Rakić, Maja
    Bajuk-Bogdanović, Danica
    Ranđelović, Dragana
    Otašević, Biljana
    Malenović, Anđelija
    Janošević Ležaić, Aleksandra
    Protić, Ana
    [J]. Processes, 2024, 12 (10)
  • [26] Online pharmaceutical process analysis of Chinese medicine using a miniature mass spectrometer: Extraction of active ingredients as an example
    Hu, Wangmin
    Hou, Junling
    Liu, Wenjing
    Gu, Xuan
    Yang, Yulei
    Shang, Hongcai
    Zhang, Mei
    [J]. JOURNAL OF PHARMACEUTICAL ANALYSIS, 2023, 13 (05) : 535 - 543
  • [27] The importance of over-the-counter-sales and product format in the environmental exposure assessment of active pharmaceutical ingredients
    Austin, Tom J.
    Comber, Sean
    Forrester, Emma
    Gardner, Mike
    Price, Oliver R.
    Oldenkamp, Rik
    Ragas, Ad M. J.
    Hendriks, A. Jan
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2021, 752 (752)
  • [28] Strategies for Assessing Acceptable Intakes for Novel N-Nitrosamines Derived from Active Pharmaceutical Ingredients
    Ponting, David J.
    Dobo, Krista L.
    Kenyon, Michelle O.
    Kalgutkar, Amit S.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (23) : 15584 - 15607
  • [29] Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs)
    Elder, D. P.
    Teasdale, A.
    Lipczynski, A. M.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 46 (01) : 1 - 8
  • [30] A novel electronic tongue using electropolymerized molecularly imprinted polymers for the simultaneous determination of active pharmaceutical ingredients
    Wang, Mingyue
    Ceto, Xavier
    del Valle, Manel
    [J]. BIOSENSORS & BIOELECTRONICS, 2022, 198